Elsevier has launched a drug tracking and analysis database. Inteleos contains over 8,000 drugs and 1,200 pharmaceutical and biotech companies.
The Crohn's & Colitis Foundation of America (CCFA) has chosen John Wiley & Sons to publish its official journal, Inflammatory Bowel Diseases.
Ovid Technologies has expanded its partnership with Blackwell Publishing. Under the agreement, Ovid will add more than 60 of the publisher's medical and nursing journals to its electronic content delivery platform, Journals@Ovid.
John Wiley & Sons has announced a new agreement with Epocrates, a provider of mobile and web-based clinical applications, to make Wiley's recently-acquired InfoPOEMs medical content available to Epocrates users.
The Beilstein Journal of Organic Chemistry (BJOC) is one of the first chemistry journals to be included in PubMed Central, the world's largest digital archive of freely available full-text journal literature.
Blackwell Publishing has acquired Cardiovascular Drug Reviews and CNS Drug Reviews. Both publish extensive review articles on preclinical and clinical studies with new drugs written by scientists.
The British Journal of Pharmacology (BJP) has started accepting open-access articles, subject to payment of a publication fee. The journal is moving to a mixed-revenue model of subscription charges and publication fees.
The internet search engine for consumer healthcare, Healthline, has expanded its health information content base through partnerships with medical reference publishers such as A.D.A.M., Thomson Gale, ProQuest and Cerner Multum.
Nature Protocols promises to bring a significant new source of peer-reviewed protocols, coupled with the tools for the scientific community to post their own protocols and comment on or rank those posted by others.
Danny Kingsley, deputy director at Cambridge University Library, looks back at her early days at Australian National University – and forward to the many challenges facing librarians
While researchers, publishers and funders warm to data sharing, issues over misuse, citation and credit remain, reports Rebecca Pool